• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Italy Gene Therapy Market

    ID: MRFR/Pharma/51503-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    Italy Gene Therapy Market Research Report By Therapeutic Area (Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders), By Technology (Viral Vectors, CRISPR, Gene Editing, RNA Therapy, Non-Viral Methods), By Application (Research, Clinical, Commercial) and By Route of Administration (Intravenous, Intramuscular, Intradermal, Intrathecal, Oral)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Italy Gene Therapy Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Italy Gene Therapy Market Summary

    The Italy Gene Therapy market is projected to grow significantly from 161.2 USD Million in 2024 to 450 USD Million by 2035.

    Key Market Trends & Highlights

    Italy Gene Therapy Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.78 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 450 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 161.2 USD Million, reflecting a strong foundation for future expansion.
    • Growing adoption of innovative therapies due to increasing prevalence of genetic disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 161.2 (USD Million)
    2035 Market Size 450 (USD Million)
    CAGR (2025-2035) 9.78%

    Major Players

    Amgen, Pfizer, CureVac, Regeneron Pharmaceuticals, Gilead Sciences, Roche, Sarepta Therapeutics, Spark Therapeutics, AbbVie, Vertex Pharmaceuticals, Bristol Myers Squibb, GeneTx Biotherapeutics, Novartis, bluebird bio, uniQure

    Italy Gene Therapy Market Trends

    Italy is witnessing significant growth in the gene therapy market, driven by several key market drivers. The government's support through funding and policies aimed at fostering innovation in biotechnology has empowered research institutions and companies alike. Notable initiatives include the Italian Medicines Agency’s programs that expedite the approval process for new therapies, aiming to bring groundbreaking treatments to patients faster. The presence of leading academic institutions specializing in life sciences also plays a crucial role in advancing gene therapy research, enabling collaboration between universities and pharmaceutical companies.

    Opportunities to be explored in the Italian gene therapy landscape include increased investment in research and development as well as partnerships among industry players. The rise of personalized medicine creates a demand for tailor-made therapies, leveraging Italy's established healthcare framework to test and deploy such treatments effectively. Additionally, companies are recognizing the potential of developing gene therapies for rare diseases, which is a growing concern in Italy, where a significant portion of the population suffers from uncommon genetic conditions. Recent trends in Italy showcase the expanding use of gene editing technologies, such as CRISPR, to address hereditary disorders.

    There is also a notable increase in clinical trials related to gene therapy, supported by a favorable regulatory environment. Moreover, companies are increasingly focusing on developing innovative delivery systems that enhance the efficacy of gene therapies, ensuring they reach the target cells effectively. These developments highlight the vibrant and evolving nature of the gene therapy market in Italy, showcasing its potential to transform healthcare in the region.

    Italy Gene Therapy Market Drivers

    Market Segment Insights

    Italy Gene Therapy Market Segment Insights

    Italy Gene Therapy Market Segment Insights

    Gene Therapy Market Therapeutic Area Insights

    Gene Therapy Market Therapeutic Area Insights

    The Therapeutic Area segment within the Italy Gene Therapy Market is witnessing significant progress, reflecting the growing importance of innovative therapeutics in the healthcare landscape. Oncology continues to be a leading focal point, driven by the high prevalence of cancer and the need for more effective treatments, resulting in substantial research and investments. Genetic disorders are another critical area, as advancements in gene therapy provide new avenues for treating conditions that were previously considered untreatable, offering hope to many patients and their families.

    The rise of infectious diseases, particularly in light of recent global health challenges, is also prompting a reevaluation of therapeutic strategies, with gene therapy emerging as a viable contender in the arsenal of treatments. Furthermore, cardiovascular diseases represent a noteworthy segment due to their high incidence rates in Italy, prompting research initiatives to explore gene-based interventions that could revolutionize management approaches. Neurological disorders are gaining attention as the complexities of the nervous system open up unique opportunities for gene therapy to address debilitating conditions, showcasing the vast potential of this technology.

    These areas together form an integral part of the Italy Gene Therapy Market segmentation, each driven by distinct challenges and opportunities, indicative of a broad and dynamic market landscape that is consistently evolving in response to patient needs and scientific advances. The current landscape also underscores a growing trend towards personalized medicine, where gene therapies can be tailored to individual patients based on genetic profiles, enhancing the effectiveness of treatment protocols across these therapeutic areas. 

    With Italy being home to a robust healthcare infrastructure and an active biotechnology sector, the convergence of research, regulatory support, and clinical application is expected to drive forward the potential and acceptance for gene therapy as a viable treatment option across various therapeutic areas.As awareness grows about gene therapy, so too does the potential for these therapeutic approaches to fundamentally alter the treatment paradigm within the medical community, underscoring the relevance of ongoing developments within the Italy Gene Therapy Market.

    Gene Therapy Market Technology Insights

    Gene Therapy Market Technology Insights

    The Technology segment of the Italy Gene Therapy Market is characterized by a dynamic landscape incorporating various innovative methodologies that are paving the way for advancements in genetic medicine. Viral Vectors are significant in delivering therapeutic genes effectively into target cells, making them a popular choice among researchers and developers. CRISPR technology stands out for its precision in gene editing, presenting opportunities for correcting genetic disorders at their source.

    Gene Editing techniques are gaining traction for their potential to address a wide range of diseases by modifying genes with high efficacy.RNA Therapy, which employs RNA molecules to treat or prevent diseases, is also becoming increasingly relevant due to its versatility and ability to target specific genetic issues. 

    Moreover, Non-Viral Methods provide alternative delivery systems that are generally safer and more efficient for certain applications. As the Italian government continues to support biotechnological research, the focus on these technologies is expected to contribute to significant advancements in treating genetic disorders and enhancing overall healthcare outcomes in Italy.Integrating these technologies is crucial for developing innovative therapies that can improve the quality of life for patients affected by various genetic conditions.

    Gene Therapy Market Application Insights

    Gene Therapy Market Application Insights

    The Italy Gene Therapy Market is experiencing growth across various applications, including Research, Clinical, and Commercial applications, contributing to advancements in healthcare. Research plays a critical role in accelerating the understanding of gene therapy technologies, allowing scientists to explore and develop innovative treatment options for genetic disorders prevalent in Italy. Meanwhile, the Clinical application is gaining traction as more therapies transition from laboratory settings to patient care, addressing urgent healthcare needs and improving patient outcomes.

    This rising focus on treating rare and chronic genetic diseases fosters collaboration between healthcare providers and the pharmaceutical industry, driving the market forward. The Commercial aspect is significant as it involves the scaling up of successful therapies for widespread availability, enhancing the quality of life for patients. Moreover, the Italian government’s support for biotechnological innovations and favorable regulations helps catalyze investments in this industry. 

    This multifaceted approach to applications underlines the strategic importance of the Italy Gene Therapy Market, making it a dynamic segment with vast potential for growth and improved health solutions across the region.

    Gene Therapy Market Route of Administration Insights

    Gene Therapy Market Route of Administration Insights

    The Route of Administration segment within the Italy Gene Therapy Market showcases diverse approaches to delivering genetic treatments, significantly impacting patient outcomes and overall treatment efficacy. Among these methods, Intravenous administration is widely recognized for its ability to facilitate rapid distribution of therapeutic agents throughout the body, making it particularly valuable for conditions requiring immediate intervention. Intramuscular administration, on the other hand, is utilized for its ease and acceptance, allowing for simpler outpatient procedures.Intradermal administration is gaining traction due to its potential for localized treatment effects, particularly in dermatological applications of gene therapy. 

    Similarly, Intrathecal administration targets the central nervous system directly, offering a promising avenue for treating neurological disorders through precise delivery mechanisms. Lastly, Oral administration is emerging as a more patient-compliant option, reflecting a growing trend toward developing non-invasive administration routes. The ongoing advancements in drug formulation and delivery technologies enhance the efficacy and safety of these various routes, ultimately contributing to the evolving landscape of the Italy Gene Therapy Market.The exploration of these administration pathways continues to reveal new opportunities, supporting the favorable growth trajectory of gene therapies in the region.

    Get more detailed insights about Italy Gene Therapy Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The Italy Gene Therapy Market is rapidly evolving, characterized by innovative advancements and a competitive landscape that continues to reshape treatment paradigms for genetic disorders. As the demand for advanced therapeutic options grows, companies within this market are strategically positioning themselves to leverage their research and development capabilities, regulatory compliance, and partnerships to enhance their market presence. Competition in the Italian market intensifies as companies focus on developing novel gene therapies that show promise in addressing unmet medical needs, while also navigating complex distribution channels and regulatory frameworks. 

    The increasing collaborations between biotech firms and academic institutions bolster the innovation ecosystem, allowing for accelerated discovery and commercialization of gene therapies.Amgen has established a notable presence in the Italy Gene Therapy Market, leveraging its rich portfolio and expertise in biotechnology. The company's strengths lie in its robust research and development pipeline, which includes a focus on genetic and rare diseases that are prevalent in the region. The integration of cutting-edge technologies and adherence to strict regulatory standards has enabled Amgen to bring pivotal gene therapies to market, enhancing patient access to effective treatments.

    Moreover, the company's commitment to partnerships with local institutions and healthcare providers fortifies its capabilities in reaching diverse patient populations. 

    This collaborative approach not only strengthens Amgen's brand recognition but also positions it favorably in the competitive landscape of gene therapy in Italy.Pfizer, a key player in the Italy Gene Therapy Market, is well-regarded for its extensive portfolio of innovative products and therapies. The company's strengths encompass a diverse range of gene therapies that target critical health issues prevalent within the Italian population. Pfizer's strategic market presence is underscored by significant investments in research and development, resulting in breakthroughs that contribute to the evolving landscape of gene therapies.

    The company has undertaken various mergers and acquisitions aimed at enhancing its gene therapy capabilities and expanding its reach in Italy. 

    These strategic moves have enabled Pfizer to integrate advanced technologies and bolster its pipeline with promising candidates. Additionally, its collaborations with local biopharmaceutical companies further enhance its operational efficiency and increase awareness of its therapeutic offerings, contributing to a stronger foothold in this competitive market.

    Key Companies in the Italy Gene Therapy Market market include

    Industry Developments

    The Italy Gene Therapy Market has seen several significant developments recently, marked by activities from key players such as Amgen, Pfizer, and Novartis. In September 2023, Pfizer announced advancements in its gene therapy programs, focusing on rare diseases prevalent in the Italian population. Furthermore, Amgen is working on expanding its portfolio in Italy by investing in local clinical trials for innovative therapies. The market is also benefiting from the growing collaboration between companies; for instance, in July 2023, Roche partnered with GeneTx Biotherapeutics to enhance the availability of gene therapies in the Italian healthcare system. 

    Over the last couple of years, significant growth has been observed, with the sector's market valuation increasing substantially, driven by high demand for personalized medicine. In March 2022, Gilead Sciences launched a new gene therapy product that specifically targets genetic disorders in the Italian market. These advancements reflect the evolving landscape of the gene therapy market in Italy, characterized by collaborations, investments, and a robust pipeline of innovative treatments aimed at improving patient outcomes. The Ministry of Health in Italy continues to support these developments through regulatory frameworks that encourage R&D in gene therapies.

    Market Segmentation

    Outlook

    • Intravenous
    • Intramuscular
    • Intradermal
    • Intrathecal
    • Oral

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 161.25(USD Million)
    MARKET SIZE 2024 181.75(USD Million)
    MARKET SIZE 2035 450.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.591% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Amgen, Pfizer, CureVac, Regeneron Pharmaceuticals, Gilead Sciences, Roche, Sarepta Therapeutics, Spark Therapeutics, AbbVie, Vertex Pharmaceuticals, Bristol Myers Squibb, GeneTx Biotherapeutics, Novartis, bluebird bio, uniQure
    SEGMENTS COVERED Therapeutic Area, Technology, Application, Route of Administration
    KEY MARKET OPPORTUNITIES Increasing rare disease prevalence, Advancements in CRISPR technology, Expanding clinical trial investments, Growing public-private partnerships, Rising diabetic gene therapy demand
    KEY MARKET DYNAMICS Regulatory support, Increasing prevalence, Advanced research initiatives, Growing investment, Collaborative partnerships
    COUNTRIES COVERED Italy

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the Italy Gene Therapy Market in 2024?

    The Italy Gene Therapy Market is expected to be valued at 181.75 million USD in 2024.

    What will the market size be by 2035?

    By 2035, the Italy Gene Therapy Market is projected to reach a value of 450.0 million USD.

    What is the expected CAGR for the Italy Gene Therapy Market from 2025 to 2035?

    The expected CAGR for the Italy Gene Therapy Market from 2025 to 2035 is 8.591%.

    Which therapeutic area is projected to dominate the market in 2035?

    The Oncology therapeutic area is projected to dominate the market, reaching 130.0 million USD by 2035.

    What is the market size for genetic disorders in 2024?

    The market size for genetic disorders in the Italy Gene Therapy Market is valued at 45.0 million USD in 2024.

    Who are the key players in the Italy Gene Therapy Market?

    Key players in the Italy Gene Therapy Market include Amgen, Pfizer, Roche, and Gilead Sciences.

    What will the market size for neurological disorders be by 2035?

    The market size for neurological disorders is expected to reach 76.0 million USD by 2035.

    What challenges does the Italy Gene Therapy Market face?

    The market faces challenges such as high development costs and regulatory hurdles.

    What opportunities are emerging in the Italy Gene Therapy Market?

    Emerging opportunities include advancements in technology and increasing investment in research and development.

    What impact do global factors have on the Italy Gene Therapy Market?

    Global factors can significantly impact the Italy Gene Therapy Market by affecting supply chains and research funding.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. Italy Gene Therapy Market, BY Therapeutic Area (USD Million)
    45. Oncology
    46. Genetic Disorders
    47. Infectious Diseases
    48. Cardiovascular Diseases
    49. Neurological Disorders
    50. Italy Gene Therapy Market, BY Technology (USD Million)
    51. Viral Vectors
    52. CRISPR
    53. Gene Editing
    54. RNA Therapy
    55. Non-Viral Methods
    56. Italy Gene Therapy Market, BY Application (USD Million)
    57. Research
    58. Clinical
    59. Commercial
    60. Italy Gene Therapy Market, BY Route of Administration (USD Million)
    61. Intravenous
    62. Intramuscular
    63. Intradermal
    64. Intrathecal
    65. Oral
    66. Competitive Landscape
    67. Overview
    68. Competitive Analysis
    69. Market share Analysis
    70. Major Growth Strategy in the Gene Therapy Market
    71. Competitive Benchmarking
    72. Leading Players in Terms of Number of Developments in the Gene Therapy Market
    73. Key developments and growth strategies
    74. New Product Launch/Service Deployment
    75. Merger & Acquisitions
    76. Joint Ventures
    77. Major Players Financial Matrix
    78. Sales and Operating Income
    79. Major Players R&D Expenditure. 2023
    80. Company Profiles
    81. Amgen
    82. Financial Overview
    83. Products Offered
    84. Key Developments
    85. SWOT Analysis
    86. Key Strategies
    87. Pfizer
    88. Financial Overview
    89. Products Offered
    90. Key Developments
    91. SWOT Analysis
    92. Key Strategies
    93. CureVac
    94. Financial Overview
    95. Products Offered
    96. Key Developments
    97. SWOT Analysis
    98. Key Strategies
    99. Regeneron Pharmaceuticals
    100. Financial Overview
    101. Products Offered
    102. Key Developments
    103. SWOT Analysis
    104. Key Strategies
    105. Gilead Sciences
    106. Financial Overview
    107. Products Offered
    108. Key Developments
    109. SWOT Analysis
    110. Key Strategies
    111. Roche
    112. Financial Overview
    113. Products Offered
    114. Key Developments
    115. SWOT Analysis
    116. Key Strategies
    117. Sarepta Therapeutics
    118. Financial Overview
    119. Products Offered
    120. Key Developments
    121. SWOT Analysis
    122. Key Strategies
    123. Spark Therapeutics
    124. Financial Overview
    125. Products Offered
    126. Key Developments
    127. SWOT Analysis
    128. Key Strategies
    129. AbbVie
    130. Financial Overview
    131. Products Offered
    132. Key Developments
    133. SWOT Analysis
    134. Key Strategies
    135. Vertex Pharmaceuticals
    136. Financial Overview
    137. Products Offered
    138. Key Developments
    139. SWOT Analysis
    140. Key Strategies
    141. Bristol Myers Squibb
    142. Financial Overview
    143. Products Offered
    144. Key Developments
    145. SWOT Analysis
    146. Key Strategies
    147. GeneTx Biotherapeutics
    148. Financial Overview
    149. Products Offered
    150. Key Developments
    151. SWOT Analysis
    152. Key Strategies
    153. Novartis
    154. Financial Overview
    155. Products Offered
    156. Key Developments
    157. SWOT Analysis
    158. Key Strategies
    159. bluebird bio
    160. Financial Overview
    161. Products Offered
    162. Key Developments
    163. SWOT Analysis
    164. Key Strategies
    165. uniQure
    166. Financial Overview
    167. Products Offered
    168. Key Developments
    169. SWOT Analysis
    170. Key Strategies
    171. References
    172. Related Reports
    173. Italy Gene Therapy Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD Billions)
    174. Italy Gene Therapy Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    175. Italy Gene Therapy Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    176. Italy Gene Therapy Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)
    177. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. ACQUISITION/PARTNERSHIP
    179. MARKET SYNOPSIS
    180. ITALY GENE THERAPY MARKET ANALYSIS BY THERAPEUTIC AREA
    181. ITALY GENE THERAPY MARKET ANALYSIS BY TECHNOLOGY
    182. ITALY GENE THERAPY MARKET ANALYSIS BY APPLICATION
    183. ITALY GENE THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    184. KEY BUYING CRITERIA OF GENE THERAPY MARKET
    185. RESEARCH PROCESS OF MRFR
    186. DRO ANALYSIS OF GENE THERAPY MARKET
    187. DRIVERS IMPACT ANALYSIS: GENE THERAPY MARKET
    188. RESTRAINTS IMPACT ANALYSIS: GENE THERAPY MARKET
    189. SUPPLY / VALUE CHAIN: GENE THERAPY MARKET
    190. GENE THERAPY MARKET, BY THERAPEUTIC AREA, 2025 (% SHARE)
    191. GENE THERAPY MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
    192. GENE THERAPY MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    193. GENE THERAPY MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    194. GENE THERAPY MARKET, BY APPLICATION, 2025 (% SHARE)
    195. GENE THERAPY MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    196. GENE THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2025 (% SHARE)
    197. GENE THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
    198. BENCHMARKING OF MAJOR COMPETITORS

    Italy Gene Therapy Market Segmentation

     

    • Gene Therapy Market By Therapeutic Area (USD Million, 2019-2035)

      • Oncology
      • Genetic Disorders
      • Infectious Diseases
      • Cardiovascular Diseases
      • Neurological Disorders

     

    • Gene Therapy Market By Technology (USD Million, 2019-2035)

      • Viral Vectors
      • CRISPR
      • Gene Editing
      • RNA Therapy
      • Non-Viral Methods

     

    • Gene Therapy Market By Application (USD Million, 2019-2035)

      • Research
      • Clinical
      • Commercial

     

    • Gene Therapy Market By Route of Administration (USD Million, 2019-2035)

      • Intravenous
      • Intramuscular
      • Intradermal
      • Intrathecal
      • Oral

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027